<DOC>
	<DOCNO>NCT00990743</DOCNO>
	<brief_summary>The purpose study determine whether SYL040012 safe treatment ocular hypertension glaucoma .</brief_summary>
	<brief_title>Tolerance Effect Intraocular Pressure After Administration SYL040012</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<criteria>Healthy volunteer , gender 18 45 year age , Subjects must provide sign informed consent prior participation studyrelated procedure Body Mass Index 19,5 29 kg/m2 IOP &lt; /= 21 mmHg eye Have BCVA ( Best correct visual acuity ) &gt; /= 0.8 ( 20/25 ) ( Snellen scale ) , &lt; /= 0.1 ( LogMar unit ) eye Normal Fluorescein Clearance Test eye Normal funduscopy eye Pregnant breastfeeding female positive pregnancy test . Females childbearing potential use medically acceptable contraceptive method selection hole study . Current relevant disease , include respiratory disease , cardiovascular , endocrine , neurological , haematological , renal , neoplastic , hepatopathy , gastrointestinal distress , hypertension , infectious acute process Previous chronic process rebound characteristic could interfere study accord investigator 's judgment . Volunteers receive pharmacological treatment , include medicinal plant , four week previous begin study . Having use anticholinergic , betablockers corticoids sporadically last 30 day whichever route administration , med ocular nasal administration route . Case history hypersensitivity meds allergic process Visual alteration : Previous eye surgery , glaucoma , uveitis ocular surface pathology ( dry eye , blepharitis ) . Volunteers visual alteration 3 dioptre either eye Use contact lens Volunteer participate clinical trial past four month study entry . Blood derivate transfusion six previous month study entry Case history drug alcohol abuse dependence . Positive result test drug abuse selection period Positive serology result hepatitis B virus ( HbsAg ) , virus C HIV Analytic alteration medically relevant , investigator 's judgement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Ocular hypertension</keyword>
	<keyword>Glaucoma</keyword>
	<keyword>Beta-blocker</keyword>
</DOC>